Hana Pharm Co., Ltd.
Hana Pharm Co., Ltd. (KRX: 293480) is trading at ₩8,470.00, about ₹611 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 0.12% today. Hana Pharm is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
₩8,370.00
Today's high
₩8,580.00
52 week low
₩8,100.00
52 week high
₩12,070.00
293480 opened at ₩8,370.00, closed previously at ₩8,480.00, and has traded between ₩8,100.00 and ₩12,070.00 over the past 52 weeks.
About
Hana Pharm Co., Ltd. is a pharmaceutical enterprise that manufactures and supplies a diverse range of medicinal goods to both domestic South Korean and international markets. Its comprehensive product line covers various therapeutic categories, such as anesthetics, potent narcotic pain relievers, anti-nausea agents, muscle relaxants, and treatments targeting the cardiovascular, endocrine, gastrointestinal, respiratory, and central nervous systems. Furthermore, the company offers antibiotics, dermatological preparations, urological medications, osteoporosis therapies, and medications for pain, fever, and inflammation. The firm was established in 1958 and has its corporate headquarters located in Seoul, South Korea.
Key statistics
Avg. volume
29.20K
Market cap
₩150.11B
P/E Ratio
8.62
Price-to-sales ratio
0.61
Enterprise value
₩248.29B
Free cash flow yield
-9.96%
Debt-to-equity ratio
0.21
Return on equity
2.80%
ROIC
3.20%
Beta
0.33
Dividend yield
3.07%
Last dividend
₩260.00
Financial overview
Revenue
₩239.50B
Earnings per share
₩507.00
Free cash flow
-₩19.87B
Net profit margin
7.06%
Gross margin
61.46%
EBITDA
₩36.95B
Revenue growth
6.29%
Similar securities
This is not an investment recommendation
Hana Pharm for Indian investors
Hana Pharm is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Hana Pharm for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm KST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Hana Pharm’s current yield is 3.07%.Dividend tax explained
FAQs
Can I buy Hana Pharm on Paasa?
Hana Pharm (293480) has been listed on the Korea Exchange since 2018, in the Drug Manufacturers - Specialty & Generic industry. Hana Pharm is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Hana Pharm share cost in rupees?
One Hana Pharm share is ₩8,470.00 — about ₹611 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Hana Pharm price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Hana Pharm shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Hana Pharm price.
Does Hana Pharm pay a dividend, and how is it taxed in India?
Yes. Hana Pharm pays a dividend and the current yield is 3.07%; the last declared dividend was ₩260.00 per share, about ₹18.76. Dividends are taxed at your slab rate in India.
When does KRX trade, in Indian time?
The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.
Do I have to declare Hana Pharm shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Hana Pharm?
Yes. Hana Pharm is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.